Original Research

Published on 30 May 2024

Edaravone dexborneol attenuates oxidative stress in experimental subarachnoid hemorrhage via Keap1/Nrf2 signaling pathway

in Neuropharmacology

Kunyuan Zhu
Shijun Bi
Zechao Zhu
Wenxu Zhang
Xinyu Yang
Jiashuo Li
Guobiao Liang
Chunyong Yu
Pengyu Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1342226

1,692 views

Review

Published on 30 May 2024

Pharmacological mTOR inhibitors in ameliorating Alzheimer’s disease: current review and perspectives

in Neuropharmacology

Pei-Lun Xie
Meng-Yu Zheng
Ran Han
Wei-Xin Chen
Jin-Hua Mao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1366061

2,336 views

Original Research

Published on 30 May 2024

Development of a new hazard scoring system in primary neuronal cell cultures for drug-induced acute neuronal toxicity identification in early drug discovery

in Neuropharmacology

Mohamed Kreir
Dea Putri
Fetene Tekle
Francesca Pibiri
Constantin d’Ydewalle
Karel Van Ammel
Helena Geys
Ard Teisman
David J. Gallacher
Hua Rong Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1308547

1,126 views

Original Research

Published on 27 May 2024

Adenosine A2A and dopamine D2 receptor interaction controls fatigue resistance

in Neuropharmacology

Ana Cristina de Bem Alves
Naiara de Souza Santos
Ana Paula Tavares Santos
Gabriela da Panatta
Ana Elisa Speck
Rodrigo A. Cunha
Aderbal S. Aguiar

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390187

1,245 views
5 citations

Review

Published on 27 May 2024

Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities

in Neuropharmacology

Chi Ma
Dan Liu
Benqiao Wang
Yingying Yang
Ruixia Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1370411

2,558 views
1 citation

Review

Published on 24 May 2024

Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action

in Neuropharmacology

Abdul Waris
Ata Ullah
Muhammad Asim
Rafi Ullah
Md. Rafe Rajdoula
Stephen Temitayo Bello
Fahad A. Alhumaydhi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403232

4,223 views
1 citation

Review

Published on 24 May 2024

Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease

in Neuropharmacology

Chinenye Edith Muolokwu
Bivek Chaulagain
Avinash Gothwal
Arun Kumar Mahanta
Benjamin Tagoe
Babita Lamsal
Jagdish Singh

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1405423

3,738 views
1 citation

Systematic Review

Published on 24 May 2024

Global research status and trends of enteric glia: a bibliometric analysis

in Neuropharmacology

Huai-Yu Li
Wei-Xin Yan
Jia Li
Jing Ye
Zhi-Guo Wu
Zheng-Kun Hou
Bin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403767

1,896 views

Clinical Trial

Published on 24 May 2024

Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

in Neuropharmacology

Khlood Mohammad Aldossary
Lashin Saad Ali
Mahmoud S. Abdallah
Mostafa M. Bahaa
Thanaa A. Elmasry
Eman I. Elberri
Fedaa A. Kotkata
Ramy M. El Sabaa
Yasmine M. Elmorsi
Mostafa M. Kamel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1381523

1,831 views
1 citation

Review

Published on 24 May 2024

Alzheimer’s disease and its treatment–yesterday, today, and tomorrow

in Neuropharmacology

A. Y. Kim
S. Al Jerdi
R. MacDonald
C. R. Triggle

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399121

7,210 views
3 citations

Original Research

Published on 23 May 2024

Effects of long-term antipsychotic medication on brain instability in first-episode schizophrenia patients: a resting-state fMRI study

in Neuropharmacology

Maoxing Zhong
Zhening Liu
Feiwen Wang
Jun Yang
Eric Chen
Edwin Lee
Guowei Wu
Jie Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387123

1,086 views

Original Research

Published on 22 May 2024

Pre-clinical evaluation of clinically relevant iPS cell derived neuroepithelial stem cells as an off-the-shelf cell therapy for spinal cord injury

in Neuropharmacology

Dania Winn
Elias Uhlin
Malin Kele
Ilse Eidhof
Anna Falk

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390058

1,138 views

Review

Published on 22 May 2024

Drug-induced musical hallucination

in Neuropharmacology

Brock Bakewell
Michael Johnson
Madison Lee
Elizabeth Tchernogorova
Jesse Taysom
Qing Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401237

3,317 views

Original Research

Published on 22 May 2024

Small pouches, but high nicotine doses—nicotine delivery and acute effects after use of tobacco-free nicotine pouches

in Neuropharmacology

Nadja Mallock-Ohnesorg
Andrea Rabenstein
Yvonne Stoll
Marcus Gertzen
Benedikt Rieder
Sebastian Malke
Nestor Burgmann
Peter Laux
Elke Pieper
Thomas Schulz

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1392027

9,008 views
1 citation

Review

Published on 21 May 2024

Mushroom-derived bioactive components with definite structures in alleviating the pathogenesis of Alzheimer’s disease

in Neuropharmacology

Xue Jiang
Yu Song
Changshun Lv
Yinghui Li
Xiangru Feng
Hao Zhang
Yujuan Chen
Qingshuang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1373660

1,626 views

Original Research

Published on 16 May 2024

Antiseizure properties of fenamate NSAIDs determined in mature human stem-cell derived neuroglial circuits

in Neuropharmacology

Hamed Salmanzadeh
Robert F. Halliwell

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1385523

1,176 views

Navigation group

Articles

Edaravone dexborneol attenuates oxidative stress in experimental subarachnoid hemorrhage via Keap1/Nrf2 signaling pathway

Pharmacological mTOR inhibitors in ameliorating Alzheimer’s disease: current review and perspectives

Development of a new hazard scoring system in primary neuronal cell cultures for drug-induced acute neuronal toxicity identification in early drug discovery

Adenosine A2A and dopamine D2 receptor interaction controls fatigue resistance

Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities

Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action

Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease

Global research status and trends of enteric glia: a bibliometric analysis

Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

Alzheimer’s disease and its treatment–yesterday, today, and tomorrow

Effects of long-term antipsychotic medication on brain instability in first-episode schizophrenia patients: a resting-state fMRI study

Pre-clinical evaluation of clinically relevant iPS cell derived neuroepithelial stem cells as an off-the-shelf cell therapy for spinal cord injury

Drug-induced musical hallucination

Small pouches, but high nicotine doses—nicotine delivery and acute effects after use of tobacco-free nicotine pouches

Mushroom-derived bioactive components with definite structures in alleviating the pathogenesis of Alzheimer’s disease

Antiseizure properties of fenamate NSAIDs determined in mature human stem-cell derived neuroglial circuits